Effect of Proximal Blood Flow Arrest During Endovascular Thrombectomy (ProFATE)

Endovascular thrombectomy (EVT) has become the standard of care for large vessel occlusion in acute ischaemic stroke (AIS). During clot-retrieval, simultaneous balloon inflation within the internal carotid artery offers transient proximal blood flow arrest, potentially preventing distal clot migration or embolisation to new vascular territories. Retrospective studies indicate that this may improve complete vessel recanalisation rates and may translate to improved functional independence. However, lack of high-quality evidence demonstrating the efficacy of simultaneous balloon inflation has led to clinical equipoise with heterogeneity of practice globally.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

134

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nottingham, United Kingdom, NG7 2UH
        • Nottingham University Hospitals Nhs Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age ≥18 years
  • Acute ischemic stroke presenting with a neurological deficit of (NIHSS ≥2)
  • Intracranial arterial occlusion of the distal internal carotid artery or middle cerebral artery (M1/M2 segments) demonstrated with on clinical neuroimaging such as: computed tomography angiogram (CTA), magnetic resonance imaging angiogram (MRA), or digital subtraction angiography (DSA).
  • ASPECTS score of >4 or by locally accepted ischaemic core/penumbra mismatch using computed tomography perfusion or magnetic resonance (CTP or MR) imaging.
  • modified Rankin Scale, mRS<3
  • Intention to treat with aspiration only or combination technique of stent-retriever + aspiration in the first pass attempt during endovascular thrombectomy

Exclusion Criteria:

  • Severe stenosis (>90%), or tandem occlusion of the ipsilateral extracranial internal carotid artery.
  • Previously deployed stents in the ipsilateral internal carotid artery.
  • Dissections of the ipsilateral internal carotid artery.
  • Unlikely to be available for 90 days follow-up (e.g. no fixed home address, visitor from overseas).
  • Subject participating in a study involving an investigational drug or device that would impact this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Balloon inflation
Endovascular thrombectomy with simultaneous balloon inflation using a balloon guide catheter
Clot retrieval for large vessel occlusion in acute ischaemic stroke
Active Comparator: No balloon inflation
Endovascular thrombectomy without simultaneous balloon inflation using a balloon guide catheter
Clot retrieval for large vessel occlusion in acute ischaemic stroke

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modified thrombolysis in cerebral infarction (mTICI) score of 2c-3
Time Frame: Immediately after endovascular thrombectomy
Near complete-complete vessel recanalisation
Immediately after endovascular thrombectomy

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mortality
Time Frame: 90 days
90 days
Modified thrombolysis in cerebral infarction (mTICI) score of 2b-3
Time Frame: Immediately after endovascular thrombectomy
Successful vessel recanalisation
Immediately after endovascular thrombectomy
First pass effect (mTICI2c-3)
Time Frame: During endovascular thrombectomy procedure
Near complete-complete vessel recanalisation after the first pass attempt at clot retrieval
During endovascular thrombectomy procedure
New or distal vascular territory clot embolisation
Time Frame: Immediately after endovascular thrombectomy
Immediately after endovascular thrombectomy
Modified Rankin Scale 0-2
Time Frame: 90 days
Good functional outcome based on the modified Rankin scale of disability
90 days
Symptomatic intracranial haemorrhage
Time Frame: 24 hours after Endovascular thrombectomy
24 hours after Endovascular thrombectomy
National Institutes of Health of Stroke Scale (NIHSS)
Time Frame: 24 hours
Change in stroke severity
24 hours
Total number of passes at clot retrieval
Time Frame: Immediately after endovascular thrombectomy
Immediately after endovascular thrombectomy
Procedure related complications
Time Frame: Immediately after endovascular thrombectomy
Immediately after endovascular thrombectomy
Total procedural time
Time Frame: Immediately after endovascular thrombectomy
Immediately after endovascular thrombectomy

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Permesh Singh Dhillon, Nottingham University Hospitals Nhs Trust

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 7, 2021

Primary Completion (Actual)

October 1, 2023

Study Completion (Actual)

November 1, 2023

Study Registration Dates

First Submitted

August 20, 2021

First Submitted That Met QC Criteria

August 24, 2021

First Posted (Actual)

August 25, 2021

Study Record Updates

Last Update Posted (Actual)

June 27, 2025

Last Update Submitted That Met QC Criteria

June 23, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Endovascular thrombectomy

Subscribe